Core Points - The "Future of Employment - National City Joint Recruitment Fair for College Graduates" will be held on the morning of the 16th in Zhengzhou, targeting various urgent employment groups [1] - The event is organized by the Zhengzhou Erqi District Human Resources and Social Security Bureau in collaboration with Henan 123 Talent Network [1] Industry Summary - The recruitment fair aims to attract youth talent, high-level professionals, recent graduates, unemployed youth, community job seekers, skilled youth, and veterans [1] - Participating companies span multiple industries including finance, biochemistry, environmental technology, education, manufacturing, precision electronics, digital technology, tourism, media, law, hospitality, automotive, logistics, healthcare, agriculture, construction materials, and food [1] Job Opportunities - The fair will offer over 5,500 job positions focusing on roles such as new media operations, management trainees, e-commerce, technical engineers, administration, design, accounting, law, computer science, reserve cadres, human resources management, and internships [1] - To enhance the job-seeking experience, the event will feature dedicated recruitment and display areas, along with mobile services for resume submission [1]

Core Points - Shandong Baomo Biochemical Co., Ltd. released a new company charter in October 2025, aiming to standardize corporate governance and protect the rights and interests of all parties involved, laying a solid foundation for long-term development [1][3] Group 1: Company Structure and Governance - The company was approved to change its structure by the Shandong Development and Reform Commission and was listed on the Shenzhen Stock Exchange on September 15, 2010, with a registered capital of 612 million yuan [1] - The company has issued 61.2 million shares, all of which are ordinary shares, and can increase capital through various methods such as issuing shares to specific or unspecified objects, distributing bonus shares, or capitalizing reserves [1] - Share transfer restrictions are in place for shares issued before the public offering and for shares held by directors and senior management to maintain market order [1] Group 2: Shareholder Rights and Responsibilities - Shareholders have rights to dividends, participate in shareholder meetings, and supervise company operations, while also being required to comply with laws and company regulations [1] - The company strictly regulates the behavior of controlling shareholders and actual controllers to prevent the abuse of control rights that could harm the interests of the company and other shareholders [1] Group 3: Board and Management Structure - The shareholder meeting, as the company's power institution, has detailed regulations for convening, proposals, notifications, voting, and resolutions to ensure scientific and fair decision-making [2] - The board of directors consists of nine members, including three independent directors, responsible for convening shareholder meetings and executing resolutions [2] - Senior management, including the general manager and financial officer, must adhere to similar duties and restrictions as the board members [2] Group 4: Financial and Reporting Standards - The company is required to prepare and disclose annual and interim reports, establish profit distribution policies, and implement an internal audit system [2] - Specific platforms for information disclosure are designated, including Securities Daily and Securities Times [2] Group 5: Major Corporate Actions - The company charter includes detailed procedures for significant actions such as mergers, divisions, capital increases, reductions, dissolutions, and liquidations, ensuring compliance with legal regulations [3]

天眼查App显示，近日，湖南省菩晶生物科技有限公司成立，法定代表人为王祥，注册资本200万人民 币，经营范围为许可项目：化妆品生产;食品用洗涤剂生产;消毒剂生产（不含危险化学品）;林木种子生 产经营（依法须经批准的项目，经相关部门批准后方可开展经营活动，具体经营项目以批准文件或许可 证件为准）一般项目：农业科学研究和试验发展;化妆品批发;化妆品零售;互联网销售（除销售需要许可 的商品）;食品用洗涤剂销售;日用化学产品销售;日用化学产品制造;消毒剂销售（不含危险化学品）;中 草药种植;生物化工产品技术研发;技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广 （除依法须经批准的项目外，自主开展法律法规未禁止、未限制的经营活动）。 ...

Core Viewpoint - Recently, Yurun Biotechnology (Zaozhuang) Co., Ltd. was established with a registered capital of 1 million RMB, focusing on various biotechnology and chemical product developments and sales [1] Company Summary - The legal representative of Yurun Biotechnology is Yang Fajiang [1] - The company has a registered capital of 1 million RMB [1] - The business scope includes research and development of biological chemical products, sales of chemical products (excluding licensed chemical products), and production of chemical products (excluding licensed chemical products) [1] - Additional activities include the development and sales of biological organic fertilizers, agricultural and sideline product sales, and research on bio-based materials [1] Industry Summary - The company is involved in various sectors such as biotechnology, chemical products, and agricultural materials [1] - It offers technical services, development, consulting, and technology transfer related to bio-based materials and biomass energy [1] - The company also engages in the manufacturing and sales of composite microbial fertilizers, food additives, and paper products [1]

Ajinomoto (OTCPK:AJIN.Y) Update / Briefing October 13, 2025 08:00 PM ET Speaker1Good morning.Speaker3Thank you for joining Ajinomoto Group's business briefing.Speaker1Meeting on Latin American business despite your busy schedule. This is Kaji from IR. At the outset, I'd like to introduce today's speakers representing Representative Executive Officer, President & CEO Mr. Nakamura, Executive Officer, General Manager of Latin America, President of Ajinomoto do Brasil Ms. Yamamoto.Speaker3Hello.Speaker1Nice to ...

福建青松股份有限公司于2025年10月发布公告，其第五届董事会第十五次会议审议修订了公司章程，该 修订尚需公司股东大会审议通过。此次章程修订涉及公司经营宗旨、股份管理、股东与股东会、董事 会、高级管理人员等多方面内容，对公司治理规则进行了一系列调整。 公司经营宗旨强调以科技进步为先导，自主创新为根本，通过规范化、专业化运营为公司和股东获取经 济效益。经营范围涵盖以自有资金从事投资活动、化妆品及相关产品销售、生物化工产品技术研发等领 域。 财务会计制度方面，公司需按规定编制并披露年度和中期报告，制定了利润分配政策及决策程序，明确 公积金的用途等。同时，公司实行内部审计制度，对会计师事务所的聘任也有相应规定。 通知和公告部分，规定了公司通知的多种形式及送达日期的确定方式，指定了公告媒体。在合并、分 立、增资、减资、解散和清算以及章程修改等方面，也都制定了详细的操作流程和规范。 点击查看公告原文>> 声明：市场有风险，投资需谨慎。 本文为AI大模型基于第三方数据库自动发布，任何在本文出现的信 息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成 个人投资建议。受限于第三方数据库 ...

Core Insights - The article discusses the rapid development and investment in the biomanufacturing sector in China, highlighting various projects and initiatives aimed at establishing mid-test platforms across multiple regions [5][6][12]. Investment and Project Developments - In Chongqing, a total of 32 projects with an investment of 14.53 billion yuan were signed, focusing on biomanufacturing, biomedicine, and other high-tech industries [5]. - The Chongqing Biomanufacturing Industry Pilot Platform aims to create a national-level mid-test platform for biomanufacturing, emphasizing intelligent biological fermentation and related technologies [6]. - The platform is part of a broader initiative that includes 1,252 key projects with a total investment of approximately 3.2 trillion yuan planned for 2025 [6]. Regional Initiatives - Changde Economic Development Zone is also advancing its synthetic biomanufacturing mid-test conversion platform, with significant construction progress reported [7][8]. - The Changde platform has a total investment of 169 million yuan and will feature multiple mid-test production lines to cater to various scales and types of biomanufacturing [8]. National Support and Policy Framework - Multiple provinces, including Guangdong, Shanghai, and Sichuan, are actively supporting the establishment of mid-test platforms, with specific funding and policy frameworks in place [10][11][12]. - The Ministry of Industry and Information Technology and the National Development and Reform Commission have set a goal to cultivate over 20 mid-test capability construction platforms by 2027, aiming to serve more than 200 enterprises [12].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002513 证券简称：蓝丰生化公告编号：2025-057 江苏蓝丰生物化工股份有限公司 关于公司股票交易异常波动的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，不存在虚假记载、误导性陈述或者重大遗 漏。 一、股票交易异常波动情况 江苏蓝丰生物化工股份有限公司（以下简称"公司"）股票交易价格于2025年9月25日、2025年9月26日连 续两个交易日收盘价格涨幅偏离值累计超过20%，根据《深圳证券交易所交易规则》等有关规定，属于 股票交易异常波动的情形。 二、公司关注并核实情况的说明 针对公司股票交易异常波动，公司对有关事项进行了核查，现就有关情况说明如下： 1、公司前期披露的信息不存在需要更正、补充之处。 2、公司未发现近期有公共媒体报道了可能或已经对本公司股票交易价格产生较大影响的未公开重大信 息。 3、公司目前经营情况正常，内外部经营环境未发生重大变化。 除上述事项外，公司董事会确认，公司目前没有任何根据《深圳证券交易所股票上市规则》等有关规定 应予以披露而未披露的事项或与该事项有关的筹划、商谈、意向、协议等；董事会也未获悉公司有根 ...

Core Insights - The article discusses the significance of green biomanufacturing in achieving carbon neutrality and sustainable development, highlighting the recognition of key scientists in the field [2][4][5]. Group 1: Green Biomanufacturing Potential - Biomanufacturing is projected to cover 70% of chemical manufacturing products by the end of this century, with an expected economic value of $30 trillion by 2050, although the current industry scale is less than $8 trillion [4][5]. - The concept of third-generation biomanufacturing, which utilizes carbon dioxide as a raw material, is emphasized as a crucial advancement for addressing carbon neutrality [4][5]. Group 2: Challenges and Innovations - Major scientific challenges include efficiently capturing and activating inert carbon dioxide molecules, requiring the design of new enzyme catalysts and light-enzyme coupling systems [5][6]. - Engineering challenges involve scaling up efficient but fragile biological systems to create stable, continuous, and low-cost reactors, transitioning from laboratory to industrial applications [5][6]. Group 3: Interdisciplinary Collaboration - Effective interdisciplinary collaboration is essential, necessitating the establishment of project communities, shared platforms, and talent communities to foster innovation across biology, chemistry, materials, and information fields [6][7]. - Educational reforms are needed to cultivate talent capable of leading the next industrial revolution, focusing on interdisciplinary courses and encouraging exploratory research [6][7]. Group 4: Global Position and Cooperation - China is transitioning from a "follower" to a "leader" in the global green technology race, with advantages in applied research, industrialization, and market scale [7]. - The proposed international cooperation model emphasizes open collaboration in basic research, innovation alliances in key technologies, and self-reliance in core competitive areas [7].

Core Insights - The event "Biomanufacturing Leading the Future" was successfully held in Hefei as part of the 2025 World Manufacturing Conference, attracting over 230 participants from various sectors [1][3] - The focus was on the biomanufacturing industry, discussing key common links and development hotspots, and aiming to create a comprehensive biomanufacturing ecosystem [3][4] Industry Development - Anhui Province has established a comprehensive biomanufacturing industry system covering six sectors: biopharmaceuticals, bio-food, bio-energy, biomaterials, biochemistry, and enzyme preparations [3] - The province has developed three billion-level industry clusters in biopharmaceuticals, bio-food, and bio-energy, with leading companies like Huaheng Bio and Fengyuan Group [3][4] - A 3 billion yuan biomanufacturing industry fund has been established through cooperation between central and local governments [3] Strategic Initiatives - Hefei is integrating biomanufacturing into its new industrial cluster system, forming a dedicated task force and implementing supportive policies [4] - The establishment of the Synthetic Biology Innovation Research Institute and the Hefei (Changfeng) Synthetic Biomanufacturing Industrial Park aims to create a nationally influential biomanufacturing hub [4] Collaborative Efforts - Key projects and funds were signed during the event, including the Synthetic Biology Multiscale Incubation Center and AI-driven biomanufacturing platforms [4] - The establishment of the Anhui Biomanufacturing Industry Alliance will facilitate the gathering of innovative resources and promote the commercialization of research outcomes [7] Future Outlook - Anhui plans to optimize its industrial layout and enhance collaboration among government, industry, academia, research, finance, and services to foster a "four-chain integration" industrial ecosystem [8]